Michael E. Kelly - Concepedia

Author

Michael E. Kelly

Dalhousie University ORCID

Also Known As

A Khan, B L Skelly, B Singh, B Skelly, B. Skelly, Bromage S, D C Winter, D Hechtl, D Kelly, D S Keller

563

Publications

21.3K

Citations

H-Index

193

Concepts

All Affiliations

Dalhousie University University of Birmingham University of Liverpool University College London Edinburgh Royal Infirmary

About

Michael E. Kelly is an author at Dalhousie University specializing in medicine, neuroscience, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	55	3.7K
2	Health Sciences	9	9	471
3	Public Health	2	2	36
4	Arts	1	1	15
5	Education	1	1	37

Michael E. Kelly

153

Publications

12.3K

Citations

H-Index

Page 1

	Year	Citations
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister, New England Journal of Medicine	2012	1.1K
Cannabidiol is a negative allosteric modulator of the cannabinoid CB <sub>1</sub> receptor Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, British Journal of Pharmacology	2015	960
Cannabis in painful HIV-associated sensory neuropathy Donald I. Abrams, Cheryl A. Jay, Starley B. Shade, Neurology	2007	589
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Cannabinoid–Opioid Interaction in Chronic Pain Donald I. Abrams, Paul Couey, Starley B. Shade, Clinical Pharmacology & Therapeutics	2011	316
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili, British Journal of Pharmacology	2018	304
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study James Glasbey, Adesoji Ademuyiwa, Adewale Adisa, The Lancet Oncology	2021	280

Page 1